These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11361629)

  • 21. Protease inhibitor-sparing regimen suppresses HIV.
    AIDS Patient Care STDS; 1998 Dec; 12(12):940. PubMed ID: 11362068
    [No Abstract]   [Full Text] [Related]  

  • 22. New AIDS drugs.
    Minn Med; 1991 Dec; 74(12):46. PubMed ID: 1724284
    [No Abstract]   [Full Text] [Related]  

  • 23. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
    [No Abstract]   [Full Text] [Related]  

  • 24. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
    [No Abstract]   [Full Text] [Related]  

  • 25. After the drugs: what's next?
    Schouten JT
    Res Initiat Treat Action; 1998 Dec; 4(7):9-10. PubMed ID: 11366085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. South African leader relents in storm over HIV drugs for women.
    Nature; 2002 Apr; 416(6883):778. PubMed ID: 11976644
    [No Abstract]   [Full Text] [Related]  

  • 27. Desensitization to Nevirapine.
    TreatmentUpdate; 1999 Nov; 11(8):5. PubMed ID: 11367044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy?
    Chang SY; Lin SW; Hung CC
    Clin Infect Dis; 2009 Nov; 49(9):1452-3; author reply 1453-4. PubMed ID: 19824849
    [No Abstract]   [Full Text] [Related]  

  • 29. Expanded access for delavirdine.
    Posit Aware; 1996; 7(3):5-6. PubMed ID: 11363426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
    Wool M
    Posit Dir News; 1998 Jan; 10(1):18-24. PubMed ID: 11365052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nevirapine (Viramune).
    Res Initiat Treat Action; 2000 Mar; 6(1):18-9. PubMed ID: 11708179
    [No Abstract]   [Full Text] [Related]  

  • 32. A new class of anti-HIV drugs.
    Treat Rev; 1996 Aug; (No 22):8-9. PubMed ID: 11363816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():42-3. PubMed ID: 16385872
    [No Abstract]   [Full Text] [Related]  

  • 34. Trial begins for rain forest agent.
    AIDS Patient Care STDS; 1999 Jan; 13(1):59-60. PubMed ID: 11362092
    [No Abstract]   [Full Text] [Related]  

  • 35. [Non-nucleoside reverse transcriptase inhibitors. AIDS long-term management].
    Sautter R
    Fortschr Med; 1998 Jul; 116(20-21):56-7. PubMed ID: 9738345
    [No Abstract]   [Full Text] [Related]  

  • 36. Scientific basis for PEP rests in animal trials.
    AIDS Alert; 1997 Sep; 12(9):100-1. PubMed ID: 11364581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current AIDS drugs].
    Praxis (Bern 1994); 1997 Feb; 86(9):364-5. PubMed ID: 9157508
    [No Abstract]   [Full Text] [Related]  

  • 38. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
    Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B
    Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New York ADAP to cover new AIDS drugs plus viral load testing.
    Link D
    GMHC Treat Issues; 1996 Sep; 10(9):12. PubMed ID: 11363840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA approval of nevirapine for HIV.
    Am Fam Physician; 1996 Oct; 54(5):1805-6. PubMed ID: 8857799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.